Cost-effectiveness analysis of universal influenza vaccination: Application of the susceptible–infectious–complication–recovery model

Kuen Cheh Yang, Hui Fang Hung, Meng Kan Chen, Sam Li Sheng Chen, Jean Ching Yuan Fann, Sherry Yueh Hsia Chiu, Amy Ming Fang Yen, Kuo Chin Huang, Hsiu Hsi Chen, Sen Te Wang

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: Despite the fact that vaccination is an effective primary prevention strategy for the containment of influenza outbreaks, health policymakers have shown great concern over the enormous costs involved in universal immunization, particularly when resources are limited. Methods: A two-arm cost-effectiveness analysis (CEA) was conducted that took into account the aspect of herd immunity. The analysis used a study cohort of 100 000 residents with a demographic make-up identical to that of the underlying population in Taipei County, Taiwan, during the epidemic influenza season of 2001–2002. The parameters embedded in the dynamic process of infection were estimated through the application of the newly proposed susceptible–infection–complication–recovery (SICR) model to the empirical data, in order to compute the number of deaths and complications averted due to universal vaccination compared to no vaccination. Incremental cost-effectiveness ratios (ICERs) and the cost-effectiveness acceptability curve (CEAC) given maximum amount of willingness-to-pay (WTP) were calculated to delineate the results of the two-arm CEA. Results: The incremental costs involved in the vaccinated group as compared to the unvaccinated group were $1195 to reduce one additional complication and $805 to avert one additional death, allowing for herd immunity. The corresponding figures were higher for the results without considering herd immunity. Given the ceiling ratio of WTP equal to $10 000 (approximately two-thirds of GDP), the probability of the vaccination being cost-effective for averting death was 100% and for averting complications was 96.7%. Conclusions: Universal vaccination against seasonal influenza was found to be very cost-effective, particularly when herd immunity is considered. The probability of being cost-effective was almost certain given the maximum amount of WTP within two-thirds of the GDP.

Original languageEnglish
Pages (from-to)102-108
Number of pages7
JournalInternational Journal of Infectious Diseases
Volume73
DOIs
Publication statusPublished - Aug 1 2018

Fingerprint

Herd Immunity
Human Influenza
Cost-Benefit Analysis
Vaccination
Costs and Cost Analysis
Primary Prevention
Taiwan
Disease Outbreaks
Immunization
Cohort Studies
Demography
Health
Infection
Population

Keywords

  • Cost-effectiveness analysis
  • Dynamic model
  • Herd immunity
  • Influenza

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Cost-effectiveness analysis of universal influenza vaccination : Application of the susceptible–infectious–complication–recovery model. / Yang, Kuen Cheh; Hung, Hui Fang; Chen, Meng Kan; Chen, Sam Li Sheng; Fann, Jean Ching Yuan; Chiu, Sherry Yueh Hsia; Yen, Amy Ming Fang; Huang, Kuo Chin; Chen, Hsiu Hsi; Wang, Sen Te.

In: International Journal of Infectious Diseases, Vol. 73, 01.08.2018, p. 102-108.

Research output: Contribution to journalArticle

Yang, Kuen Cheh ; Hung, Hui Fang ; Chen, Meng Kan ; Chen, Sam Li Sheng ; Fann, Jean Ching Yuan ; Chiu, Sherry Yueh Hsia ; Yen, Amy Ming Fang ; Huang, Kuo Chin ; Chen, Hsiu Hsi ; Wang, Sen Te. / Cost-effectiveness analysis of universal influenza vaccination : Application of the susceptible–infectious–complication–recovery model. In: International Journal of Infectious Diseases. 2018 ; Vol. 73. pp. 102-108.
@article{cab1372b70d046f3a8d04dcc3a6a3a25,
title = "Cost-effectiveness analysis of universal influenza vaccination: Application of the susceptible–infectious–complication–recovery model",
abstract = "Objectives: Despite the fact that vaccination is an effective primary prevention strategy for the containment of influenza outbreaks, health policymakers have shown great concern over the enormous costs involved in universal immunization, particularly when resources are limited. Methods: A two-arm cost-effectiveness analysis (CEA) was conducted that took into account the aspect of herd immunity. The analysis used a study cohort of 100 000 residents with a demographic make-up identical to that of the underlying population in Taipei County, Taiwan, during the epidemic influenza season of 2001–2002. The parameters embedded in the dynamic process of infection were estimated through the application of the newly proposed susceptible–infection–complication–recovery (SICR) model to the empirical data, in order to compute the number of deaths and complications averted due to universal vaccination compared to no vaccination. Incremental cost-effectiveness ratios (ICERs) and the cost-effectiveness acceptability curve (CEAC) given maximum amount of willingness-to-pay (WTP) were calculated to delineate the results of the two-arm CEA. Results: The incremental costs involved in the vaccinated group as compared to the unvaccinated group were $1195 to reduce one additional complication and $805 to avert one additional death, allowing for herd immunity. The corresponding figures were higher for the results without considering herd immunity. Given the ceiling ratio of WTP equal to $10 000 (approximately two-thirds of GDP), the probability of the vaccination being cost-effective for averting death was 100{\%} and for averting complications was 96.7{\%}. Conclusions: Universal vaccination against seasonal influenza was found to be very cost-effective, particularly when herd immunity is considered. The probability of being cost-effective was almost certain given the maximum amount of WTP within two-thirds of the GDP.",
keywords = "Cost-effectiveness analysis, Dynamic model, Herd immunity, Influenza",
author = "Yang, {Kuen Cheh} and Hung, {Hui Fang} and Chen, {Meng Kan} and Chen, {Sam Li Sheng} and Fann, {Jean Ching Yuan} and Chiu, {Sherry Yueh Hsia} and Yen, {Amy Ming Fang} and Huang, {Kuo Chin} and Chen, {Hsiu Hsi} and Wang, {Sen Te}",
year = "2018",
month = "8",
day = "1",
doi = "10.1016/j.ijid.2018.05.024",
language = "English",
volume = "73",
pages = "102--108",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",

}

TY - JOUR

T1 - Cost-effectiveness analysis of universal influenza vaccination

T2 - Application of the susceptible–infectious–complication–recovery model

AU - Yang, Kuen Cheh

AU - Hung, Hui Fang

AU - Chen, Meng Kan

AU - Chen, Sam Li Sheng

AU - Fann, Jean Ching Yuan

AU - Chiu, Sherry Yueh Hsia

AU - Yen, Amy Ming Fang

AU - Huang, Kuo Chin

AU - Chen, Hsiu Hsi

AU - Wang, Sen Te

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Objectives: Despite the fact that vaccination is an effective primary prevention strategy for the containment of influenza outbreaks, health policymakers have shown great concern over the enormous costs involved in universal immunization, particularly when resources are limited. Methods: A two-arm cost-effectiveness analysis (CEA) was conducted that took into account the aspect of herd immunity. The analysis used a study cohort of 100 000 residents with a demographic make-up identical to that of the underlying population in Taipei County, Taiwan, during the epidemic influenza season of 2001–2002. The parameters embedded in the dynamic process of infection were estimated through the application of the newly proposed susceptible–infection–complication–recovery (SICR) model to the empirical data, in order to compute the number of deaths and complications averted due to universal vaccination compared to no vaccination. Incremental cost-effectiveness ratios (ICERs) and the cost-effectiveness acceptability curve (CEAC) given maximum amount of willingness-to-pay (WTP) were calculated to delineate the results of the two-arm CEA. Results: The incremental costs involved in the vaccinated group as compared to the unvaccinated group were $1195 to reduce one additional complication and $805 to avert one additional death, allowing for herd immunity. The corresponding figures were higher for the results without considering herd immunity. Given the ceiling ratio of WTP equal to $10 000 (approximately two-thirds of GDP), the probability of the vaccination being cost-effective for averting death was 100% and for averting complications was 96.7%. Conclusions: Universal vaccination against seasonal influenza was found to be very cost-effective, particularly when herd immunity is considered. The probability of being cost-effective was almost certain given the maximum amount of WTP within two-thirds of the GDP.

AB - Objectives: Despite the fact that vaccination is an effective primary prevention strategy for the containment of influenza outbreaks, health policymakers have shown great concern over the enormous costs involved in universal immunization, particularly when resources are limited. Methods: A two-arm cost-effectiveness analysis (CEA) was conducted that took into account the aspect of herd immunity. The analysis used a study cohort of 100 000 residents with a demographic make-up identical to that of the underlying population in Taipei County, Taiwan, during the epidemic influenza season of 2001–2002. The parameters embedded in the dynamic process of infection were estimated through the application of the newly proposed susceptible–infection–complication–recovery (SICR) model to the empirical data, in order to compute the number of deaths and complications averted due to universal vaccination compared to no vaccination. Incremental cost-effectiveness ratios (ICERs) and the cost-effectiveness acceptability curve (CEAC) given maximum amount of willingness-to-pay (WTP) were calculated to delineate the results of the two-arm CEA. Results: The incremental costs involved in the vaccinated group as compared to the unvaccinated group were $1195 to reduce one additional complication and $805 to avert one additional death, allowing for herd immunity. The corresponding figures were higher for the results without considering herd immunity. Given the ceiling ratio of WTP equal to $10 000 (approximately two-thirds of GDP), the probability of the vaccination being cost-effective for averting death was 100% and for averting complications was 96.7%. Conclusions: Universal vaccination against seasonal influenza was found to be very cost-effective, particularly when herd immunity is considered. The probability of being cost-effective was almost certain given the maximum amount of WTP within two-thirds of the GDP.

KW - Cost-effectiveness analysis

KW - Dynamic model

KW - Herd immunity

KW - Influenza

UR - http://www.scopus.com/inward/record.url?scp=85050095524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050095524&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2018.05.024

DO - 10.1016/j.ijid.2018.05.024

M3 - Article

AN - SCOPUS:85050095524

VL - 73

SP - 102

EP - 108

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

ER -